Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 6/2007

Content (17 Articles)

Original Article

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study

R. Delva, T. Pienkowski, N. Tubiana, U. Vanhoefer, B. Longerey, I. Douville

Original Article

The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines

Yuji Toiyama, Yasuhiro Inoue, Junichiro Hiro, Eiki Ojima, Hideki Watanabe, Youhei Narita, Atuko Hosono, Chikao Miki, Masato Kusunoki

Original Article

Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates

Stacey L. Berg, Claudia Brueckner, Jed G. Nuchtern, Robert Dauser, Leticia McGuffey, Susan M. Blaney

Original Article

Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines

Julie Scott, Robert T. Dorr, Betty Samulitis, Terry H. Landowski

Original Article

Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride

Jens Teichert, Frank Baumann, Qi Chao, Craig Franklin, Brandy Bailey, Lothar Hennig, Karel Caca, Konrad Schoppmeyer, Ulrich Patzak, Rainer Preiss

Original Article

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

Alessandra Tedeschi, Marco Montillo, Elena Strocchi, Anna Maria Cafro, Elisabetta Tresoldi, Liliana Intropido, Michele Nichelatti, Laura Marbello, Claudia Baratè, Carlo Maurizio Camaggi, Enrica Morra

Original Article

The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines

Elizabeth K. Balcer-Kubiczek, Mona Attarpour, Martin J. Edelman

Original Article

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno, Yoichiro Moriya, Kazushige Mori, Yutaka Tanaka

Original Article

Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models

Kaori Fujimoto-Ouchi, Etsuro Onuma, Masatoshi Shirane, Kazushige Mori, Yutaka Tanaka

Original Article

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer

Jan H. Beumer, Jeany M. Rademaker-Lakhai, Hilde Rosing, Michel J. X. Hillebrand, Tessa M. Bosch, Luis Lopez-Lazaro, Jan H. M. Schellens, Jos H. Beijnen

Original Article

Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks

Weiguang Wang, Howard L. McLeod, James Cassidy, Elaina S. R. Collie-Duguid

Original Article

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

Patrick A. Thompson, Daryl J. Murry, Gary L. Rosner, Simon Lunagomez, Susan M. Blaney, Stacey L. Berg, Bruce M. Camitta, ZoAnn E. Dreyer, Lisa R. Bomgaars

Short Communication

The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate

Roos L. Oostendorp, Serena Marchetti, Jos H. Beijnen, R. Mazzanti, Jan H. M. Schellens

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine